Mayo Clinic discovers biological markers that could guide treatment for prostate cancer

ROCHESTER, Minn. ? Genetic alterations in low-risk prostate cancer diagnosed by needle biopsy can identify men that harbor higher-risk cancer in their prostate glands, Mayo Clinic has discovered. The research, which is published in the January edition of Mayo Clinic Proceedings, found for the first time that genetic alterations associated with intermediate- and high-risk prostate [...]
Source: Mayo Clinic Research News - Category: Research Source Type: news